Wellcome Trust’s Procter & Gamble PG Stock Holding History

Wellcome Trust’s Portfolio PG Stock Details PG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-100,000	Closed	-$8.41M	–	26
2016 Q4	$8.41M	Hold	100,000	–	–	0.17%	25
2016 Q3	$8.97M	Hold	100,000	–	–	0.19%	26
2016 Q2	$8.47M	Hold	100,000	–	–	0.19%	27
2016 Q1	$8.23M	Hold	100,000	–	–	0.18%	27
2015 Q4	$7.94M	Hold	100,000	–	–	0.16%	30
2015 Q3	$7.19M	Buy	+100,000	New	+$7.5M	0.16%	28

Other funds holding PG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TFM

Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellcome Trust's PG Position: Q4 2018 in Review

Wellcome Trust sold out of Procter & Gamble (PG) in Q4 2018, closing a stake of 1,500,000 shares — an estimated $125M sold.

Wellcome Trust first reported a position in PG in Q2 2013 and held it in 22 quarters. The position peaked at $230M in Q4 2017. 2,421 funds tracked by Wall St. Rank hold PG as of Q4 2018.

Wellcome Trust reported no remaining Procter & Gamble position as of Q4 2018 after selling out during the quarter.
Wellcome Trust sold 1,500,000 Procter & Gamble shares in Q4 2018, an estimated $125M.
Wellcome Trust first reported a position in Procter & Gamble in Q2 2013 and held it in 22 quarters.
Wellcome Trust's Procter & Gamble position peaked at $230M in Q4 2017.
2,421 funds tracked by Wall St. Rank held Procter & Gamble as of Q4 2018.

Based on Wellcome Trust's 13F filing for Q4 2018, filed 18 Jan 2019.